Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

TwitterFacebookLinkedInYouTube
People Strong - Innovation Driven

News

BWXT Names Gerhard Burbach to Board of Directors

09 August 2018

BWX Technologies, Inc. (NYSE:BWXT) announced today that Gerhard “Gary” F. Burbach has been appointed to its board of directors.



BWXT Completes Acquisition of Sotera Health’s Nordion Medical Isotope Business

06 August 2018

BWX Technologies, Inc. announced today that it has completed the acquisition of Sotera Health’s Nordion medical isotope business.


BWXT Names Thomas E. McCabe as Senior Vice President and General Counsel

23 July 2018

BWX Technologies, Inc. (NYSE:BWXT) announced today that Thomas (Tom) E. McCabe has been named senior vice president, general counsel, chief compliance officer and corporate secretary for BWXT effective July 23, 2018.


BWXT Signs Medical Isotope Development Agreement with Bruce Power

12 July 2018

(LYNCHBURG, Va. – July 12, 2018) – BWX Technologies, Inc. (NYSE:BWXT) announced today that a subsidiary has signed an agreement with Bruce Power that will enable the two companies to collaborate on the development and supply of medical isotopes.


BWXT Names John A. Stewart President of Nuclear Fuel Services

28 June 2018

BWX Technologies, Inc. (NYSE:BWXT) announced today that John A. Stewart has been named president of Nuclear Fuel Services, Inc. (NFS) effective July 1, 2018.


BWXT Selects Ontario Power Generation to Provide Irradiation Services for New Medical Isotope Manufacturing Technology

20 June 2018

BWX Technologies, Inc. is expanding its longstanding relationship with Ontario Power Generation (OPG), whose wholly owned subsidiary Canadian Nuclear Partners (CNP) plans to provide irradiation services to support BWXT’s new medical isotope manufacturing technology for molybdenum-99.


BWXT Names Chris E. Rhodes General Manager of Euclid, Ohio Operations

19 June 2018

BWX Technologies, Inc. announced today that Chris E. Rhodes has been named general manager of the BWXT Nuclear Operations Group, Inc. (BWXT NOG) manufacturing facility in Euclid, Ohio.


BWXT to Present at UBS Global Industrials & Transportation Conference

12 June 2018

BWX Technologies, Inc. Senior Vice President and Chief Financial Officer David Black will be presenting at the 2018 UBS Global Industrials & Transportation Conference in New York on June 14, 2018.


BWXT Joint Venture Awarded $5 Billion Contract Extension For Idaho National Laboratory Management

06 June 2018

BWX Technologies, Inc. announced today that its Idaho National Laboratory (INL) joint venture management contract with lead partner Battelle has been awarded a five-year contract extension. INL is managed by Battelle Energy Alliance (BEA) for the U.S. Department of Energy’s (DOE) Office of Nuclear Energy.

Archive

Tags

Press Contacts:

BWX Technologies, Inc.

Jud Simmons 
+1 434.522.3800
hjsimmons@bwxt.com

BWXT Canada Ltd.  

Natalie Cutler 
+1 519.620.5288 
nacutler@bwxt.com 

BWXT Nuclear Energy Canada Inc.

Sara Forsey 
+1 705.927.0429 
sforsey@bwxt.com 

Nuclear Fuel Services, Inc.

Laura Bailey 
+1 423.743.9141
lebailey@nuclearfuelservices.com